Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2019-04-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 March 2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related instruments. The content is focused on share capital changes and securities movements rather than financial performance, management changes, or earnings. It is a regulatory filing reporting monthly share capital movements as required by the exchange. The document is lengthy (15,000 characters) and contains detailed data, not just an announcement or a certification. This type of document fits best under the category of Regulatory Filings (RNS), as it is a compliance report on share capital movements and does not fit other more specific categories like Share Issue/Capital Change (SHA) which typically covers announcements of new share issues or capital changes but not detailed monthly returns. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2019-04-01 English
ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report Classification · 95% confidence The document is an announcement titled 'ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018' from Uni-Bio Science Group Limited. It contains detailed financial highlights, segment financial figures, management discussion and analysis, and business review for the full fiscal year ended December 31, 2018. The content includes audited consolidated results, key accomplishments, market review, and strategic business updates. The length is substantial (15,000 characters), and it contains actual financial data and analysis rather than just a brief announcement or a link to a report. The document is clearly a full annual financial report covering company activity and full financial performance for the year, consistent with the definition of an Annual Report (10-K). Therefore, the appropriate classification is Annual Report (10-K). FY 2018
2019-03-29 English
DISCLOSEABLE AND CONNECTED TRANSACTIONS - TRANSACTION ARRANGEMENTS: THE FIGURES UP COMPLETION AND THE WTGL LAND AND PROPERTY RIGHTS COMPLETION
Capital/Financing Update Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the completion of certain transaction arrangements related to Figures Up and WTGL Land and Property Rights. It references previous circulars and announcements but primarily reports on the completion of these transactions. The document is relatively short (2873 characters) and does not contain detailed financial statements or comprehensive financial analysis. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or management report. The content focuses on transaction completion updates, which aligns with Capital/Financing Update filings. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2019-03-25 English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to Rule 13.10 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. It addresses unusual price and trading volume movements of the company's shares and confirms that the board is not aware of any inside information or reasons for such movements. The document is short (2563 characters) and serves as a regulatory disclosure to inform the market and shareholders, without containing financial statements or detailed financial data. It is not a financial report, earnings release, or management discussion, but a regulatory announcement related to trading activity. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-03-22 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the date of a board meeting scheduled to approve and publish the financial results for the year ended 31 December 2018. The text does not contain the financial results themselves, nor detailed financial data or analysis. It is a short announcement (1589 characters) indicating the timing of the board meeting and the intent to approve and publish the annual results. This fits the pattern of a Report Publication Announcement (RPA), which notifies stakeholders about the upcoming release of a report rather than containing the report itself.
2019-03-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28 February 2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related instruments. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a monthly return or shareholding update. It is not an annual or interim report, earnings release, or management discussion. The document is substantive and detailed, not a brief announcement or certification. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-03-01 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.